FibroGen To Host Part I of Virtual KOL Investor Event Series to Review Pamrevlumab Clinical Program in Pancreatic Cancer on February 13, 2024

February 5, 2024

https://www.globenewswire.com/news-release/2024/02/05/2823393/33525/en/FibroGen-To-Host-Part-I-of-Virtual-KOL-Investor-Event-Series-to-Review-Pamrevlumab-Clinical-Program-in-Pancreatic-Cancer-on-February-13-2024.html

SAN FRANCISCO, Feb. 05, 2024 (GLOBE NEWSWIRE) — FibroGen, Inc. (NASDAQ:FGEN) today announced it will host Part I of a virtual KOL investor event series on Tuesday, February 13, 2024 at 10:30 AM ET. To register, click here.

Read more at globenewswire.com

Related news for (FGEN)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.